Pepceuticals

Pepceuticals is a distinguished British manufacturer specializing in synthetic peptides, serving the Life Science industry with high-quality custom peptides and antibody manufacturing services. Since 2023, Pepceuticals has been a proud member of the Biosynth Group, further enhancing its capabilities and reach in providing cutting-edge solutions to researchers worldwide. Pepceuticals has cultivated a strong reputation for excellence in peptide synthesis, developing innovative technologies to produce complex peptide molecules.

Located at 4 FELDSPAR CLOSE WARRENS PARK, ENDERBY, LE19 4JS, GB, Pepceuticals is dedicated to advancing the development of both large and small synthetic peptide libraries, thereby increasing the potential for discovering new research candidates. The company offers a comprehensive drug development program, providing peptides manufactured under cGMP from milligram to kilogram quantities, and supporting all aspects of peptide manufacturing. Pepceuticals also actively develops generic peptide active substances (APIs) that address various disease areas.

With a stringent Pharmaceutical Quality System, Pepceuticals ensures that its products consistently meet or exceed industry standards. Holding an API manufacturing license granted by the MHRA and BSI ISO 2001-2015 accreditation, Pepceuticals exemplifies reliability and innovation. The company’s Quality Control (QC) team meticulously maintains and updates instrumentation, operating/testing procedures, and staff training to uphold these high standards, delivering products reliably with a full certificate of analysis and supporting data. We invite the manager of Pepceuticals to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional offerings.